Literature DB >> 19552542

Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design.

Jaleh Varshosaz1, Sharareh Eskandari, Majid Tabakhian.   

Abstract

The objective of this study was production of nanostructured lipid carriers (NLC) of valproic acid for brain delivery thought the nasal pathway. NLC were prepared by solvent diffusion method using a Taguchi design. The lipid, oil and valproic acid were dissolved in organic phase then dispersed in aqueous phase containing the surfactant. The most effective factors on size were surfactant concentration, organic/aqueous phase ratio and acetone/ethanol volume ratio. Zeta potential was more affected by the lipid type, while the surfactant concentration and sonication time were more effective variables on drug release rate. The entrapment efficiency was more affected by lipid/drug weight ratio. Optimum formulation obtained with 400 mg lipid, 400 mg valproic acid, 2% surfactant, 1:5 organic/aqueous phase ratio, 1:1 acetone/ethanol volume ratio and 2 min sonication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19552542     DOI: 10.3109/10837450903013568

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  8 in total

1.  Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model.

Authors:  Sharareh Eskandari; Jaleh Varshosaz; Mohsen Minaiyan; Majid Tabbakhian
Journal:  Int J Nanomedicine       Date:  2011-02-15

2.  Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study.

Authors:  Cui-Tao Lu; Rong-Rong Jin; Yi-Na Jiang; Qian Lin; Wen-Ze Yu; Kai-Li Mao; Fu-Rong Tian; Ya-Ping Zhao; Ying-Zheng Zhao
Journal:  Drug Des Devel Ther       Date:  2015-04-07       Impact factor: 4.162

3.  Evaluating Cytotoxicity of Hyaluronate Targeted Solid Lipid Nanoparticles of Etoposide on SK-OV-3 Cells.

Authors:  Parviz Mohammadi Ghalaei; Jaleh Varshosaz; Hojatollah Sadeghi Aliabadi
Journal:  J Drug Deliv       Date:  2014-04-24

4.  Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats.

Authors:  Ying-Zheng Zhao; Rong-Rong Jin; Wei Yang; Qi Xiang; Wen-Ze Yu; Qian Lin; Fu-Rong Tian; Kai-Li Mao; Chuan-Zhu Lv; Yi-Xiáng J Wáng; Cui-Tao Lu
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

5.  Evaluation of Nanostructured Lipid Carriers Produced with Interesterified Buriti Oil.

Authors:  Lívia Viana de Castro Reis; Karina Magna Leão; Paula Speranza; Ana Paula Badan Ribeiro; Gabriela Alves Macedo; Juliana Alves Macedo
Journal:  Food Technol Biotechnol       Date:  2020-09       Impact factor: 3.918

6.  In-vitro and in-vivo evaluation of chitosan-based thermosensitive gel containing lorazepam NLCs for the treatment of status epilepticus.

Authors:  Somayeh Taymouri; Mohsen Minaiyan; Farnaz Ebrahimi; Naser Tavakoli
Journal:  IET Nanobiotechnol       Date:  2020-04       Impact factor: 1.847

7.  Formulation development and evaluation of hybrid nanocarrier for cancer therapy: Taguchi orthogonal array based design.

Authors:  Rakesh K Tekade; Mahavir B Chougule
Journal:  Biomed Res Int       Date:  2013-09-11       Impact factor: 3.411

8.  Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance.

Authors:  Petra Obioma Nnamani; Agatha Adaora Ugwu; Emmanuel Chinedu Ibezim; Franklin Chimaobi Kenechukwu; Paul Achile Akpa; John-Dike Nwabueze Ogbonna; Nicholas Chinedu Obitte; Amelia Ngozi Odo; Maike Windbergs; Claus-Michael Lehr; Anthony Amaechi Attama
Journal:  Int J Nanomedicine       Date:  2016-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.